Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20160716028945N4Phase 3Completed
Phase 3, double-blind trial of alprazolam in Insomnia (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Insomnia Score according to ISI questionnaire. Started Jun 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20160716028945N4.